Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
Repeal of LIFO (Last in, First Out), H.R. 1 Tax Cuts and Jobs Act
Financial CHOICE Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
H.R 10, The Financial CHOICE Act of 2017.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
FAIR FARA COALITION via NOSSAMAN LLP
2018 · fourth_quarter · 4T
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2018 · fourth_quarter · 4T
Source: Senate LDA
| AMGEN, INC. | 24 | 2000–2010 |
| AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE | 23 | 2013–2018 |
| VILLAGE OF OAK PARK | 23 | 2002–2010 |
| FMR LLC | 20 | 2005–2010 |
| COALITION FOR TAX EQUITY | 18 | 1999–2010 |
| LOCKHEED MARTIN CORPORATION | 15 | 1999–2008 |
| ARAB BANK (CONTRACT WITH GEN CORP COUNSEL FOR ARAB BANK LEBOUFE LAMB GREEN) | 10 | 2005–2008 |
| MERCK & COMPANY INC | 9 | 2003–2008 |
| INTERNATIONAL CEMETERY, CREMATION AND FUNERAL ASSOCIATION | 8 | 2010–2011 |
| M&T BANK | 8 | 2010–2011 |
| CAPITAL ONE FINANCIAL CORP | 7 | 2000–2005 |
| METRIS COMPANIES INC | 7 | 2000–2005 |
| BANKFIRST | 6 | 2001–2004 |
| VOYAGER EXPANDED LEARNING | 6 | 2001–2003 |
| EXXON MOBIL CORPORATION | 5 | 2006–2008 |
| FREEPORT MCMORAN COOPER & GOLD | 5 | 2005–2008 |
| SISKIYOU COUNTY | 5 | 2014–2016 |
| STATE STREET BANK & TRUST CO | 5 | 1999–2001 |
| TD BANK USA FSB | 5 | 2001–2002 |
| FAIR FARA COALITION | 4 | 2018 |
| GENERAL ELECTRIC COMPANY | 4 | 2006–2008 |
| RENAISSANCE TECHNOLOGIES LLC | 4 | 2009–2010 |
| WELVISTA | 4 | 2009 |
| CELERA GENOMICS | 3 | 2000 |
| ELECTRONIC CHECK CLEARINGHOUSE ORGANIZATION | 3 | 2002–2003 |
| PERSONAL WATERCRAFT INDUSTRY ASSN | 3 | 2001–2002 |
| SANTA FE COUNTY | 3 | 2001 |
| U S CENTRAL CREDIT CORP | 3 | 1999–2000 |
| UBS WARBURG | 3 | 2000–2001 |
| UST PUBLIC AFFAIRS | 3 | 1999–2000 |
| BEAR STEARNS & CO | 2 | 1999–2000 |
| GENERAL MOTORS CORPORATION | 2 | 2006 |
| GENWORTH FINANCIAL | 2 | 2005 |
| MORTGAGE BANKERS ASSN OF AMERICA | 2 | 1999 |
| ATLANTIC RICHFIELD CO | 1 | 2006 |
| CARDSYSTEMS SOLUTIONS (CONSTANTINE CANNON) | 1 | 2005 |
| FMC CORP | 1 | 2006 |
| GRAY INSURANCE CO | 1 | 2002 |
| VISA USA, INC. | 1 | 2000 |
Financial CHOICE Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. Implementation of S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Financial CHOICE Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. Implementation of S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Financial CHOICE Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
H.R 10, The Financial Choices Act of 2017.
Financial CHOICE Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10 Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, H.R.10, Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, H.R.10, Financial CHOICE Act of 2017
Financial CHOICE Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
H.R 10, The Financial CHOICE Act of 2017.
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, H.R.10, Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, H.R.10, Financial CHOICE Act of 2017
Financial CHOICE Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Small Business Health Fairness Act of 2017
Client: THE WORD & BROWN COMPANIES · Firm: NOSSAMAN LLP
Changes to the Affordable Care Act, including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
Small Business Health Fairness Act of 2017
Client: THE WORD & BROWN COMPANIES · Firm: NOSSAMAN LLP
Changes to the Affordable Care Act, including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
PROSPER Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE · Firm: NOSSAMAN LLP
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
PROSPER Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE · Firm: NOSSAMAN LLP
Higher Education Act reauthorization, graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
PROSPER Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE · Firm: NOSSAMAN LLP
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
PROSPER Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE · Firm: NOSSAMAN LLP
Higher Education Act reauthorization, graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
SUPPORT for Patients and Communities Act
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
SUPPORT for Patients and Communities Act
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
SUPPORT for Patients and Communities Act
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Fix NICS Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. Implementation of S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, H.R.10, Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act and Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act and Financial CHOICE Act of 2017
Fix NICS Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, H.R.10, Financial CHOICE Act of 2017
Fix NICS Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10 Financial CHOICE Act of 2017
Fix NICS Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. Implementation of S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Foreign Agents Registration Amendments Act of 2018
Client: FAIR FARA COALITION · Firm: NOSSAMAN LLP
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Foreign Agents Registration Amendments Act of 2018
Client: FAIR FARA COALITION · Firm: NOSSAMAN LLP
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Foreign Agents Registration Amendments Act of 2018
Client: FAIR FARA COALITION · Firm: NOSSAMAN LLP
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
A bill to establish a statute of limitations for certain actions of the Securities and Exchange Commission, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and implementation of the Drug Quality Security Act. S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
A bill to establish a statute of limitations for certain actions of the Securities and Exchange Commission, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and implementation of the Drug Quality Security Act. S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
Repeal of LIFO (Last in, First Out), H.R. 1 Tax Cuts and Jobs Act
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE · Firm: NOSSAMAN LLP
H.R. 1 Tax Cuts and Jobs Act
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
H.R. 1 Tax Cuts and Jobs Act
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: MASTERCARD WORLDWIDE · Firm: NOSSAMAN LLP
H.R. 1 Tax Cuts and Jobs Act
Small Business Health Fairness Act of 2017
Client: THE WORD & BROWN COMPANIES · Firm: NOSSAMAN LLP
Changes to the Affordable Care Act, including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
Small Business Health Fairness Act of 2017
Client: THE WORD & BROWN COMPANIES · Firm: NOSSAMAN LLP
Affordable Care Act implementation, H.R. 1628, American Health care Act of 2017 including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes.
Client: AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE · Firm: NOSSAMAN LLP
Funding for FY 2018 Labor, HHS, and Education appropriations, H.R. 1370 Continuing Resolution for FY 2018 ( provisions related to THCGME)
Affordable Care Act implementation, H.R. 1628, American Health care Act of 2017 including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
Affordable Care Act implementation, H.R. 1628, American Health care Act of 2017 including changes to group health Insurance
Affordable Care Act implementation, H.R. 1628, American Health care Act of 2017 including changes to group health Insurance
PROSPER Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE · Firm: NOSSAMAN LLP
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
Fix NICS Act of 2017
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, CHOICE Act 7
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, CHOICE Act 7
A bill to establish a statute of limitations for certain actions of the Securities and Exchange Commission, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and Implementation of the Drug Quality Security Act, S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
Protect Medical Innovation Act of 2015 (HR 160); issues related to tax policy.
Protect Medical Innovation Act of 2015 (HR 160); issues related to tax policy.
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR160); Medical Device Access and Innovation Protection Act (S149).
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR 160); Medical Device Access and Innovation Protection Act (S 149).
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity mobile payments, and EMV payment security; Financial Choice Act of 2016 (H.R. 5983).
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity, mobile payments issues, and EMV payments security; Financial Choice Act of 2016 (H.R. 5983).
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity, mobile payments issues, and EMV payments security; Financial Choice Act of 2016 (H.R. 5983).
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity mobile payments, and EMV payment security; Financial Choice Act of 2016 (H.R. 5983).
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction).
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Financial Regulatory Improvement Act of 2015
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Financial Regulatory Improvement Act of 2015
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Financial Regulatory Improvement Act of 2015
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Financial Regulatory Improvement Act of 2015
Client: COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) · Firm: NOSSAMAN LLP
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Medical Device Access and Innovation Protection Act
Client: GLOBUS MEDICAL, INC. · Firm: NOSSAMAN LLP
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR160); Medical Device Access and Innovation Protection Act (S149).
Medical Device Access and Innovation Protection Act
Client: GLOBUS MEDICAL, INC. · Firm: NOSSAMAN LLP
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR 160); Medical Device Access and Innovation Protection Act (S 149).
Legislation proposed for the removal of four Klamath River dams (S.2379).
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction).
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Identity Theft and Tax Fraud Prevention Act of 2015
Client: CONSUMER DATA INDUSTRY ASSOCIATION · Firm: NOSSAMAN LLP
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Identity Theft and Tax Fraud Prevention Act of 2015
Client: CONSUMER DATA INDUSTRY ASSOCIATION · Firm: NOSSAMAN LLP
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Identity Theft and Tax Fraud Prevention Act of 2015
Client: CONSUMER DATA INDUSTRY ASSOCIATION · Firm: NOSSAMAN LLP
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Identity Theft and Tax Fraud Prevention Act of 2015
Client: CONSUMER DATA INDUSTRY ASSOCIATION · Firm: NOSSAMAN LLP
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR160); Medical Device Access and Innovation Protection Act (S149)
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR160); Medical Device Access and Innovation Protection Act (S149)
Programs for medical students in the VA Mission Act
Higher Education Act reauthorization, graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
Medicare cuts, generally; Teaching Health Center reauthorization; Medicare funded Graduate Medical Education; Legislative activity related to prescription drug abuse (opioids)
Funding for FY 2019 Labor, HHS, and Education appropriations. FY 2019 Military Construction, Veterans Affairs and Related Agencies Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2018 · fourth_quarter · 4T
H.R 10, The Financial CHOICE Act of 2017.
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. Implementation of S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2018 · fourth_quarter · 4T
Changes to the Affordable Care Act, including changes to group health Insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2018 · fourth_quarter · 4T
Medical device tax repeal
Sunshine Act provisions in the Affordable Care Act.
Sunshine Act provisions in the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2018 · fourth_quarter · 4T
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, H.R.10, Financial CHOICE Act of 2017
Outreach on data and cybersecurity, mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, Financial CHOICE Act of 2017
NAFTA; China market access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2018 · fourth_quarter · 4T
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2018 · third_quarter · Q3
Changes to the Affordable Care Act, including changes to group health Insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2018 · third_quarter · Q3
NAFTA; China market access
Outreach on data and cybersecurity, mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, H.R.10, Financial CHOICE Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2018 · third_quarter · Q3
H.R 10, The Financial CHOICE Act of 2017.
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. Implementation of S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2018 · third_quarter · Q3
Sunshine Act provisions in the Affordable Care Act.
Medical device tax repeal
Sunshine Act provisions in the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2018 · third_quarter · Q3
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
FAIR FARA COALITION via NOSSAMAN LLP
2018 · third_quarter · Q3
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2018 · third_quarter · Q3
Higher Education Act reauthorization, graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
Programs for medical students in the VA Mission Act
Medicare cuts, generally; Teaching Health Center reauthorization; Medicare funded Graduate Medical Education; Legislative activity related to prescription drug abuse (opioids)
FAIR FARA COALITION via NOSSAMAN LLP
2018 · second_quarter · Q2
Legislative proposals to amend FARA, including S. 2482 and S. 2039 and H.R. 4170
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2018 · second_quarter · Q2
Changes to the Affordable Care Act, including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2018 · second_quarter · Q2
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, H.R.10, Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act and Financial CHOICE Act of 2017
NAFTA; China market access
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2018 · second_quarter · Q2
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10, Financial CHOICE Act of 2017
Reform of Government Sponsored Enterprises.
H.R 10, The Financial Choices Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2018 · second_quarter · Q2
Sunshine Act provisions in the Affordable Care Act.
Sunshine Act provisions in the Affordable Care Act.
Medical device tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2018 · second_quarter · Q2
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Repeal of LIFO (Last in, First Out)
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2018 · second_quarter · Q2
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
Funding for FY 2019 Labor, HHS, and Education appropriations. FY 2019 Military Construction, Veterans Affairs and Related Agencies Appropriations bill
Programs for medical students in the VA Mission Act
FAIR FARA COALITION via NOSSAMAN LLP
2018 · second_quarter · RR
Proposals to amend the Foreign Agent Registration Act
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2018 · first_quarter · Q1
Medicare cuts, generally; Teaching Health Center reauthorization; Medicare funded Graduate Medical Education; Legislative activity related to prescription drug abuse (opioids)
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
Funding for FY 2018 Labor, HHS, and Education appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2018 · first_quarter · Q1
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Repeal of LIFO (Last in, First Out)
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and implementation of the Drug Quality Security Act. S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2018 · first_quarter · Q1
Repeal of LIFO (Last in, First Out), H.R. 1 Tax Cuts and Jobs Act
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and implementation of the Drug Quality Security Act. S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2018 · first_quarter · Q1
NAFTA; China market access
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act and Financial CHOICE Act of 2017
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, H.R.10, Financial CHOICE Act of 2017
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2018 · first_quarter · Q1
Changes to the Affordable Care Act, including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2018 · first_quarter · Q1
Sunshine Act provisions in the Affordable Care Act.
Sunshine Act provisions in the Affordable Care Act.
Medical device tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2018 · first_quarter · Q1
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures. S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act. H.R. 10 Financial CHOICE Act of 2017
H.R 10 The Financial Choices Act of 2012.
Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2017 · fourth_quarter · Q4
Changes to the Affordable Care Act, including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2017 · fourth_quarter · Q4
H.R. 1 Tax Cuts and Jobs Act
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, CHOICE Act 7
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs, S.2135- Economic Growth, Regulatory Relief, and Consumer Protection Act, CHOICE Act 7
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2017 · fourth_quarter · Q4
H.R. 1 Tax Cuts and Jobs Act
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures S. 2135 Economic Growth, Regulatory Relief, and Consumer protection Act
H.R 10 The Financial Choices Act of 2012.
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2017 · fourth_quarter · Q4
Sunshine Act provisions in the Affordable Care Act.
Medical device tax repeal
Sunshine Act provisions in the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2017 · fourth_quarter · Q4
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and Implementation of the Drug Quality Security Act, S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
Repeal of LIFO (Last in, First Out), H.R. 1 Tax Cuts and Jobs Act
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2017 · fourth_quarter · Q4
H.R. 1 Tax Cuts and Jobs Act
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation, H.R. 4508 -PROSPER Act.
Medicare cuts, generally; Teaching Health Center reauthorization; and Medicare funded Graduate Medical Education.
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2017 · fourth_quarter · 4T
Access to the Income Verification Express Service (IVES)for mortgage lending
Credit reporting amendments to National Defense Authorization Act of FY 2017.
Amendments for the Veterans Choice Act regarding medical debt
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2017 · third_quarter · Q3
Affordable Care Act implementation, H.R. 1628, American Health care Act of 2017 including changes to group health Insurance; The Small Business Health Fairness Act (HR 1101)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2017 · third_quarter · Q3
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs.
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs.
Corporate tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2017 · third_quarter · Q3
Corporate Tax reform
Reform of Government Sponsored Enterprises.
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2017 · third_quarter · Q3
Medical device tax repeal
Sunshine Act provisions in the Affordable Care Act.
Sunshine Act provisions in the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2017 · third_quarter · Q3
FCRA liability reform. Outreach on credit reporting oversight and data and cybersecurity issues. Dodd-Frank reform proposals, including CFPB measures.
Credit reporting amendments to National Defense Authorization Act of FY 2017.
Amendments for the Veterans Choice Act regarding medical debt
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2017 · third_quarter · Q3
Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and Implementation of the Drug Quality Security Act.
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2017 · third_quarter · Q3
Funding for FY 2018 Labor, HHS, and Education appropriations.
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation.
Medicare cuts, generally; Teaching Health Center reauthorization; and Medicare funded Graduate Medical Education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2017 · second_quarter · Q2
Affordable Care Act implementation, H.R. 1628, American Health care Act of 2017 including changes to group health Insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2017 · second_quarter · Q2
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs.
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs.
Monitor corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2017 · second_quarter · Q2
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures.
Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2017 · second_quarter · Q2
Medical device tax repeal
Sunshine Act provisions in the Affordable Care Act.
Sunshine Act provisions in the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2017 · second_quarter · Q2
Access to the Income Verification Express Service (IVES)for mortgage lending
Credit reporting amendments to National Defense Authorization Act of FY 2017.
FCRA liability reform. Outreach on credit reporting oversight and data and cybersecurity issues. Dodd-Frank reform proposals, including CFPB measures.
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2017 · second_quarter · Q2
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Repeal of LIFO (Last in, First Out).
Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and Implementation of the Drug Quality Security Act.
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2017 · second_quarter · Q2
Medicare cuts, generally; Teaching Health Center reauthorization; and Medicare funded Graduate Medical Education.
Funding for FY 2017 Labor, HHS, and Education appropriations.
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2017 · first_quarter · Q1
Affordable Care Act implementation, H.R. 1628, American Health care Act of 2017 including changes to group health Insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2017 · first_quarter · Q1
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs.
Outreach on data and cybersecurity mobile payments, and EMV payment security; Issues related to Interchange fees and card acceptance costs.
Monitor corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2017 · first_quarter · Q1
Reform of Government Sponsored Enterprises.
Reform of Government Sponsored Enterprises. Dodd-Frank reform measures, including regulatory relief for mid-sized banks and CFPB measures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2017 · first_quarter · Q1
Sunshine Act provisions in the Affordable Care Act.
Sunshine Act provisions in the Affordable Care Act.
Medical device tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2017 · first_quarter · Q1
FCRA liability reform. Outreach on credit reporting oversight and data and cybersecurity issues. Dodd-Frank reform proposals, including CFPB measures.
Access to the Income Verification Express Service (IVES)for mortgage lending
Credit reporting amendments to National Defense Authorization Act of FY 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2017 · first_quarter · Q1
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and Implementation of the Drug Quality Security Act.
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2017 · first_quarter · Q1
Higher Education Act reauthorization including graduate medical education, student loan interest rate caps, Public Service Loan Forgiveness Programs, Federal Perkins Loan Program continuation.
Funding for FY 2017 Labor, HHS, and Education appropriations.
Medicare cuts, generally; Teaching Health Center reauthorization; and Medicare funded Graduate Medical Education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2016 · fourth_quarter · Q4
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2016 · fourth_quarter · Q4
Funding for Health Resources and Services Administration programs in the Dept of Health and Human Services.
Medicare cuts, generally; Teaching Health Center reauthorization; and Graduate Medical Education.
Graduate medical education; Higher Education reauthorization Act; State authorization provisions in the 2010 U.S. Dept of Education program integrity regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2016 · fourth_quarter · Q4
Affordable Care Act implementation provisions relating to state and federal health exchanges focused on private web based enrollment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2016 · fourth_quarter · Q4
Protect Medical Innovation Act of 2015 (HR 160); issues related to tax policy.
Sunshine Act provisions in the Affordable Care Act.
Sunshine Act provisions in the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2016 · fourth_quarter · Q4
Monitor corporate tax reform.
Trans-Pacific Partnership negotiations electronic payment issues.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity mobile payments, and EMV payment security; Financial Choice Act of 2016 (H.R. 5983).
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2016 · fourth_quarter · Q4
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Repeal of LIFO (Last in, First Out).
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2016 · fourth_quarter · Q4
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Income Verification Express Service (IVES)
Credit reporting amendments to National Defense Authorization Act of FY 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2016 · third_quarter · Q3
Affordable Care Act implementation provisions relating to state and federal health exchanges focused on private web based enrollment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2016 · third_quarter · Q3
Trans-Pacific Partnership negotiations electronic payment issues.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity mobile payments, and EMV payment security; Financial Choice Act of 2016 (H.R. 5983).
Monitor corporate tax reform.
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2016 · third_quarter · Q3
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2016 · third_quarter · Q3
Sunshine Act provisions in the Affordable Care Act.
Protect Medical Innovation Act of 2015 (HR 160); issues related to tax policy.
Sunshine Act provisions in the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2016 · third_quarter · Q3
Income Verification Express Service (IVES)
Fair Credit Reporting Act (FCRA) Amendments to National Defense Authorization Act of FY 2017.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2016 · third_quarter · Q3
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Repeal of LIFO (Last in, First Out).
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2016 · third_quarter · Q3
Funding for Health Resources and Services Administration programs in the Dept of Health and Human Services.
Graduate medical education; Higher Education reauthorization Act; State authorization provisions in the 2010 U.S. Dept of Education program integrity regulation.
Medicare cuts, generally; Teaching Health Center reauthorization; and Graduate Medical Education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SISKIYOU COUNTY via NOSSAMAN LLP
2016 · second_quarter · Q2
Legislation proposed for the removal of four Klamath River dams (S.2379).
Filing targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2016 · second_quarter · Q2
Repeal of LIFO (Last in, First Out).
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2016 · second_quarter · Q2
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Fair Credit Reporting Act (FCRA) Amendments to National Defense Authorization Act of FY 2017.
Income Verification Express Service (IVES)
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2016 · second_quarter · Q2
Sunshine Act provisions in the Affordable Care Act.
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR 160); Medical Device Access and Innovation Protection Act (S 149).
Sunshine Act provisions in the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2016 · second_quarter · Q2
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2016 · second_quarter · Q2
Affordable Care Act implementation provisions relating to state and federal health exchanges focused on private web based enrollment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2016 · second_quarter · Q2
Funding for Health Resources and Services Administration programs in the Dept of Health and Human Services.
Graduate medical education; Higher Education reauthorization Act; State authorization provisions in the 2010 U.S. Dept of Education program integrity regulation.
Medicare cuts, generally; Teaching Health Center reauthorization; and Graduate Medical Education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2016 · second_quarter · Q2
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity mobile payments, and EMV payment security.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity, mobile payments issues, and EMV payments security.
Monitor corporate tax reform.
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2016 · first_quarter · Q1
Monitor corporate tax reform.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity, mobile payments issues, and EMV payments security.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity mobile payments, and EMV payment security.
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2016 · first_quarter · Q1
Affordable Care Act implementation provisions relating to state and federal health exchanges focused on private web based enrollment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2016 · first_quarter · Q1
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2016 · first_quarter · Q1
Sunshine Act provisions in the Affordable Care Act.
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR160); Medical Device Access and Innovation Protection Act (S149).
Sunshine Act provisions in the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2016 · first_quarter · Q1
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2016 · first_quarter · Q1
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction).
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2016 · first_quarter · Q1
Medicare cuts, generally; Teaching Health Center reauthorization; and Graduate Medical Education.
Graduate medical education; Higher Education reauthorization Act; State authorization provisions in the 2010 U.S. Dept of Education program integrity regulation.
Funding for Health Resources and Services Administration programs in the Dept of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2015 · fourth_quarter · Q4
Affordable Care Act implementation provisions relating to state and federal health exchanges focused on private web based enrollment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2015 · fourth_quarter · Q4
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484); Federal Reserve Bank Dividend Cut.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2015 · fourth_quarter · Q4
Sunshine Act provisions in the Affordable Care Act.
Sunshine Act provisions in the Affordable Care Act.
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR160); Medical Device Access and Innovation Protection Act (S149).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2015 · fourth_quarter · Q4
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity mobile payments, and EMV payment security.
Trans-Pacific Partnership negotiations electronic payment issues.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity, mobile payments issues, and EMV payments security.
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2015 · fourth_quarter · Q4
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2015 · fourth_quarter · Q4
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction).
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2015 · fourth_quarter · Q4
FY'16 Labor, HHS, Education Appropriations bill, including funding for Health Resources and Services Administration programs in the Dept of Health and Human Services.
Graduate medical education; Higher Education reauthorization Act; State authorization provisions in the 2010 U.S. Dept of Education program integrity regulation.
Medicare cuts, generally; Teaching Health Center reauthorization; and Graduate Medical Education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MASTERCARD WORLDWIDE via NOSSAMAN LLP
2015 · third_quarter · Q3
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity mobile payments, and EMV payment security.
Trans-Pacific Partnership negotiations electronic payment issues.
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity, mobile payments issues, and EMV payments security.
COFFEE & ASSOCIATES (ON BEHALF OF TEXAS CAPITAL BANK) via NOSSAMAN LLP
2015 · third_quarter · Q3
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises. Regulatory relief for mid-sized banks, Financial Regulatory Improvement Act of 2015 (S. 1484).
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE via NOSSAMAN LLP
2015 · third_quarter · Q3
Graduate medical education; Higher Education Re-authorization Act; State authorization provisions in the 2010 U.S. Dept of Education program integrity regulation.
FY'16 Labor, HHS, Education Appropriations bill, including funding for Health Resources and Services Administration programs in the Dept of Health and Human Services.
Medicare cuts, generally; Teaching Health Center Re-authorization; and Graduate Medical Education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
CONSUMER DATA INDUSTRY ASSOCIATION via NOSSAMAN LLP
2015 · third_quarter · Q3
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act. Outreach on credit reporting oversight and data and cybersecurity issues. Identity Theft and Tax Fraud Prevention Act (S. 676); reform of Government Sponsored Entities; Cybersecurity Information Sharing Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") via NOSSAMAN LLP
2015 · third_quarter · Q3
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
Repeal of LIFO (Last in, First Out).
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction).
THE WORD & BROWN COMPANIES via NOSSAMAN LLP
2015 · third_quarter · Q3
Affordable Care Act implementation provisions relating to state and federal health exchanges focused on private web based enrollment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLOBUS MEDICAL, INC. via NOSSAMAN LLP
2015 · third_quarter · Q3
Sunshine Act provisions in the Affordable Care Act.
Repeal of medical device tax: Protect Medical Innovation Act of 2015 (HR160); Medical Device Access and Innovation Protection Act (S149).
Sunshine Act provisions in the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Repeal of LIFO (Last in, First Out)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Repeal of LIFO (Last in, First Out)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for FY 2019 Labor, HHS, and Education appropriations. FY 2019 Military Construction, Veterans Affairs and Related Agencies Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare cuts, generally; Teaching Health Center reauthorization; Medicare funded Graduate Medical Education; Legislative activity related to prescription drug abuse (opioids)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Reform of Government Sponsored Enterprises.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for FY 2018 Labor, HHS, and Education appropriations, H.R. 1370 Continuing Resolution for FY 2018 ( provisions related to THCGME)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FCRA liability reform. Outreach on credit reporting oversight and data and cybersecurity issues. Dodd-Frank reform proposals, including CFPB measures, legislative proposals related to FCRA, including on the issue of freezing credit files.
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
Access to the Income Verification Express Service (IVES)for mortgage lending
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
Repeal of LIFO (Last in, First Out).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Repeal of LIFO (Last in, First Out).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity, mobile payments issues, and EMV payments security; Financial Choice Act of 2016 (H.R. 5983).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act; Outreach on data and cybersecurity, mobile payments issues, and EMV payments security; Financial Choice Act of 2016 (H.R. 5983).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Trans-Pacific Partnership negotiations electronic payment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Trans-Pacific Partnership negotiations electronic payment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Repeal of LIFO (Last in, First Out).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Repeal of LIFO (Last in, First Out).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE